Vimarsana
Biggest News Aggregation in the World

Page 33 - Billy Dunn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Billy Dunn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Billy Dunn Today - Breaking & Trending Today

FDA Approves ALS Treatment Despite Questions About Effectiveness - Vimarsana News

FDA Approves ALS Treatment Despite Questions About Effectiveness

The drug is safe, and one trial found it may extend survival and slow paralysis in functions like muscle control and speaking. A larger trial will be completed in 2024.

Much-debated drug from Amylyx for Lou Gehrig's disease wins FDA approval - Vimarsana News

Much-debated drug from Amylyx for Lou Gehrig's disease wins FDA approval

A drug from Amylyx Pharmaceuticals to treat ALS, or Lou Gehrig’s disease, won U.S. approval on Thursday from the Food and Drug Administration based on the results of a small, mid-stage study.

ALS drug wins FDA approval despite questionable data - Portland Press Herald - Vimarsana News

ALS drug wins FDA approval despite questionable data - Portland Press Herald

U.S. health officials have approved a much-debated drug to treat the deadly illness known as Lou Gehrig's disease.

ALS drug wins FDA approval despite questionable data - Vimarsana News

ALS drug wins FDA approval despite questionable data

U.S. health officials have approved a much-debated drug to treat the deadly illness known as Lou Gehrig's disease

Source: go.com
ALS drug wins FDA approval despite questionable data - Vimarsana News

ALS drug wins FDA approval despite questionable data

WASHINGTON (AP) -- A much-debated drug for Lou Gehrig's disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew